Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA warning letter
Manufacturing
Compounder in Lilly lawsuit hit with FDA warning letter
A compounding pharmacy recently roped into Lilly’s fight against knockoff GLP-1s has landed in the FDA’s crosshairs for the second time in a year.
Fraiser Kansteiner
Apr 24, 2025 8:20am
Novo, Merck, Hengrui-Elevar—Fierce Pharma Asia
Mar 28, 2025 9:28am
India's Aspen Biopharma Labs hit with FDA warning letter
Mar 26, 2025 1:09pm
Aspen Pharmacare hit with warning letter citing sterility issues
Mar 20, 2025 9:45am
Trump policy, Pfizer, CMIC—Fierce Pharma Asia
Mar 7, 2025 8:05am
Novo Nordisk, AstraZeneca, Ono—Fierce Pharma Asia
Feb 21, 2025 8:45am
